FLTX2: A Novel Tamoxifen Derivative Endowed with Antiestrogenic, Fluorescent, and Photosensitizer Properties

Tamoxifen is the most widely used selective modulator of estrogen receptors (SERM) and the first strategy as coadjuvant therapy for the treatment of estrogen-receptor (ER) positive breast cancer worldwide. In spite of such success, tamoxifen is not devoid of undesirable effects, the most life-threat...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz, Mario, Lobo, Fernando, Hernández, Dácil, Amesty, Ángel, Valdés-Baizabal, Catalina, Canerina-Amaro, Ana, Mesa-Herrera, Fátima, Soler, Kevin, Boto, Alicia, Marín, Raquel, Estévez-Braun, Ana, Lahoz, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161337/
https://www.ncbi.nlm.nih.gov/pubmed/34069498
http://dx.doi.org/10.3390/ijms22105339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161337/
https://www.ncbi.nlm.nih.gov/pubmed/34069498
http://dx.doi.org/10.3390/ijms22105339

Ejemplares similares